Xtant Medical Holdings, Inc. (XTNT)

ASE – Real vaqt narxi. Valyuta: USD

0.50

-0.02 (-3.57%)

Yopilishda: May 12, 2026, 4:00 PM EDT

0.52

+0.01 (1.55%)

Bozor oldidan: May 13, 2026, 6:15 AM EDT

07.05.2026

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

BELGRADE, Mont., May 7, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the first quarter ended March 31, 2026, before the start of trading on Wednesday, May 13, 2026.

06.05.2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

BELGRADE, Mont., May 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced the commercial launch of Trivium™ Shaped, an extension of its Trivium™ bone graft portfolio that is now available in pre‑shaped configurations designed to support handling, preparation, and placement across a range of surgical applications.

13.04.2026

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant has hired Dilon's U.S. sales team to assist in selling the HEMOBLAST ® Bellows product and penetrating the estimated $2.0 billion global addressable market for hemostatic products BELGRADE, Mont. and NEWPORT NEWS, Va.

09.04.2026

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

BELGRADE, Mont., April 9, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), in partnership with the Montana Governor's Office of Community Service (GOCS), today announced support for the Threshold of Life Memorial, a statewide initiative honoring organ, eye, and tissue donors and the lives they have impacted.

31.03.2026

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

31.03.2026

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Full year 2025 revenue totals $133.9 million, an increase of 14% year-over-year Xtant delivers positive net income, adjusted EBITDA and operating cash flow Total cash of $17.3 million as of December 31, 2025 with an additional $10.5 million received subsequent to year end related to divestiture BELGRADE, Mont., March 31, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the fourth quarter and full-year ended December 31, 2025.

25.03.2026

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

BELGRADE, Mont., March 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, before the start of trading on Tuesday, March 31, 2026.

Videolar

No Data

There is no data to display

Press-relizlar

06.05.2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

13.04.2026

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

09.04.2026

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

31.03.2026

Xtant Medical Holdings, Inc. (XTNT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Videolar

No Data

Press-relizlar

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Videolar

No Data

Press-relizlar

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Search stocks

Xtant Medical Holdings, Inc. (XTNT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Videolar

No Data

Press-relizlar

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results

Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

Videolar

No Data

Press-relizlar

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results